Clinical Trial Update: Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [NA]

View source ↗

Summary

Completed clinical trial evaluating CD133+ selected autologous hematopoietic stem cell chemotherapy in children with solid tumors and lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Lymphoma
• Neuroblastoma
• Wilms Tumor

Drugs mentioned

• CD133+ autologous hematopoietic stem cell transplantation

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Neuroblastoma, Central Nervous System Tumors | NA | Status: COMPLETED